Literature DB >> 23000334

Subconjunctival hemorrhage in a patient on dabigatran (Pradaxa).

Tam M Nguyen1, Michael P Phelan, Xiang Q Werdich, Paul J Rychwalski, Christopher M Huff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23000334     DOI： 10.1016/j.ajem.2012.07.021

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  5 in total

Review 1.  Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

Review 2.  Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.

Authors:  Julie Kalabalik; Gail B Rattinger; Jesse Sullivan; Malgorzata Slugocki; Antonia Carbone; Anastasia Rivkin
Journal:  Drugs       Date:  2015-06       Impact factor: 9.546

3.  Risk of intraocular hemorrhage with new oral anticoagulants.

Authors:  G Talany; M Guo; M Etminan
Journal:  Eye (Lond)       Date:  2016-12-23       Impact factor: 3.775

4.  Bilateral Spontaneous Hyphema, Vitreous Hemorrhage, and Choroidal Detachment With Concurrent Dabigatran Etexilate Therapy.

Authors:  Kevin Wang; Justis P Ehlers
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2016-01       Impact factor: 1.300

5.  Subconjunctival hemorrhage: risk factors and potential indicators.

Authors:  Bercin Tarlan; Hayyam Kiratli
Journal:  Clin Ophthalmol       Date:  2013-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.